CIK 0001810560 · Non-accelerated filer<br>Smaller reporting company
REVELATION BIOSCIENCES, INC.
Sign in to watch- Ticker
- REVB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 843898466
- Phone
- 650-800-3717
- Business address
- 4660 LAJOLLA VILLAGE DRIVE, SUITE 100, SAN DIEGO, CA, 92122
- Former names
- Petra Acquisition Inc.
Securities
- REVB Common Stock Nasdaq
- REVBW Warrant Nasdaq
- 10-Q Report Quarterly Report
- S-1 Offering Registration Statement
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Results of operations · Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Other events
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- S-1/A Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- S-1/A Offering Registration Statement
- UPLOAD Other SEC-generated Letter
- S-1 Offering Registration Statement
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- 8-K Event Delisting notice
- CORRESP Other Correspondence Between Filers and SEC Staff
Page 13 of 20 · 389 filings